55 international investors and pharmaceutical companies from Spain, Great Britain, Switzerland, France and other countries met 30 business plans of Spanish biotech companies. In total, 140 one-to-one meetings took place amongst the 150 attendees. This event, which also featured a day of training provided by Johnson & Johnson Innovation open to biotech start-ups, aimed at explaining how to communicate its business plan to investors, allowing investors and companies to interact in private partnering meetings.
The Advisory Committee will evaluate and select the best projects among all applications received, with the goal of inviting those projects and companies of the highest quality.
Members of the Advisory Committee are: